Overview
John Goldman practices in London, United Kingdom. Goldman is rated as a Distinguished expert by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). Their top areas of expertise are Chronic Myelogenous Leukemia (CML), Leukemia, Acute Lymphoblastic Leukemia (ALL), Flu, and Bone Marrow Transplant.
Their clinical research consists of co-authoring 48 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 42 articles in the study of Chronic Myelogenous Leukemia (CML).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Myelogenous Leukemia (CML)Goldman isDistinguished. Learn about Chronic Myelogenous Leukemia (CML).
- Advanced
- Bone Marrow TransplantGoldman isAdvanced. Learn about Bone Marrow Transplant.
- LeukemiaGoldman isAdvanced. Learn about Leukemia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)Goldman isExperienced. Learn about Acute Myeloid Leukemia (AML).
- FluGoldman isExperienced. Learn about Flu.
- Myeloproliferative Neoplasms (MPN)